Marksans Pharma arm bags UKMHRA marketing authorization for Rasagiline Relonchem, Olmesartan tablets Ruchika Sharma2 July 2024 5:13 PM ISTMumbai: Marksans Pharma has announced that its wholly-owned subsidiary Relonchem Limited has received Marketing Authorization from UKMHRA...
CDSCO Panel Gives Conditional nod to Azelnidipine and Olmesartan FDC MD Bureau18 Jan 2021 6:51 PM ISTNew Delhi: Following the submission of bioequivalence (BE) study report by Akum Drugs, the Central Drug Standard Control...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Dr. Prem Aggarwal10 Oct 2020 10:30 AM ISTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
Impact of Combination Therapy on Arterial Stiffness and Cardiac Function in hypertensive patients: Lessons from AORTA II Trial Dr. Prem Aggarwal28 July 2020 12:30 PM ISTManagement of Blood pressure (BP) in patients is a highly individualized affair. When adequate blood pressure control is not be obtained by...
Combination therapy for Hypertension: Olmesartan plus Azelnidipine or Olmesartan plus Amlodipine? Dr. Prem Aggarwal14 July 2020 12:45 PM ISTThe Protocol of Controlling Blood pressure (BP) in Hypertensive Patients is different in different parts of the world. Achieving adequate blood...
Olmesartan-Induced Enteropathy: A Case report Hina Zahid25 May 2020 5:30 PM ISTDr Ana Rita Fernandes Matos at Serviço de Medicina Interna, Hospital de Braga, Braga, Portugal and associates have reported a case of...
Free Meals for Doctors by Drug Cos influence their prescriptions : JAMA Study Meghna A Singhania24 Jun 2016 9:48 PM ISTIn this cross-sectional study of 279 669 physicians, physicians who received a single meal promoting the drug of interest, with a mean value of less...
